Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease

1. Сарлавҳасиз

   Anatoly Enikeev, Sergey Student, В. А. Иващенко +70

   БошқаProspects and Key Tendencies of Science in Contemporary World20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.other.001209

2. Сарлавҳасиз

   Anatoly Enikeev, Sergey Student, В. А. Иващенко +70

   БошқаProspects and Key Tendencies of Science in Contemporary World20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.other.001280